Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 81

1.

Blunted endogenous opioid release following an oral dexamphetamine challenge in abstinent alcohol-dependent individuals.

Turton S, Myers JF, Mick I, Colasanti A, Venkataraman A, Durant C, Waldman A, Brailsford A, Parkin MC, Dawe G, Rabiner EA, Gunn RN, Lightman SL, Nutt DJ, Lingford-Hughes A.

Mol Psychiatry. 2018 Jun 25. doi: 10.1038/s41380-018-0107-4. [Epub ahead of print]

2.

TSPO mutations in rats and a human polymorphism impair the rate of steroid synthesis.

Owen DR, Fan J, Campioli E, Venugopal S, Midzak A, Daly E, Harlay A, Issop L, Libri V, Kalogiannopoulou D, Oliver E, Gallego-Colon E, Colasanti A, Huson L, Rabiner EA, Suppiah P, Essagian C, Matthews PM, Papadopoulos V.

Biochem J. 2017 Nov 21;474(23):3985-3999. doi: 10.1042/BCJ20170648.

3.

Primary psychosis with comorbid drug abuse and drug-induced psychosis: Diagnostic and clinical evolution at follow up.

Mauri MC, Di Pace C, Reggiori A, Paletta S, Colasanti A.

Asian J Psychiatr. 2017 Oct;29:117-122. doi: 10.1016/j.ajp.2017.04.014. Epub 2017 May 2.

PMID:
29061407
4.

Neuroinflammation and its relationship to changes in brain volume and white matter lesions in multiple sclerosis.

Datta G, Colasanti A, Rabiner EA, Gunn RN, Malik O, Ciccarelli O, Nicholas R, Van Vlierberghe E, Van Hecke W, Searle G, Santos-Ribeiro A, Matthews PM.

Brain. 2017 Nov 1;140(11):2927-2938. doi: 10.1093/brain/awx228.

5.

11C-PBR28 and 18F-PBR111 Detect White Matter Inflammatory Heterogeneity in Multiple Sclerosis.

Datta G, Colasanti A, Kalk N, Owen D, Scott G, Rabiner EA, Gunn RN, Lingford-Hughes A, Malik O, Ciccarelli O, Nicholas R, Nei L, Battaglini M, Stefano ND, Matthews PM.

J Nucl Med. 2017 Sep;58(9):1477-1482. doi: 10.2967/jnumed.116.187161. Epub 2017 Mar 16.

6.

Analysis of ageing-associated grey matter volume in patients with multiple sclerosis shows excess atrophy in subcortical regions.

Bishop CA, Newbould RD, Lee JS, Honeyfield L, Quest R, Colasanti A, Ali R, Mattoscio M, Cortese A, Nicholas R, Matthews PM, Muraro PA, Waldman AD.

Neuroimage Clin. 2016 Nov 9;13:9-15. eCollection 2017.

7.

Carving depression at its joints?

Young AH, Colasanti A.

World Psychiatry. 2016 Oct;15(3):239-241. doi: 10.1002/wps.20367. No abstract available.

8.

Hippocampal Neuroinflammation, Functional Connectivity, and Depressive Symptoms in Multiple Sclerosis.

Colasanti A, Guo Q, Giannetti P, Wall MB, Newbould RD, Bishop C, Onega M, Nicholas R, Ciccarelli O, Muraro PA, Malik O, Owen DR, Young AH, Gunn RN, Piccini P, Matthews PM, Rabiner EA.

Biol Psychiatry. 2016 Jul 1;80(1):62-72. doi: 10.1016/j.biopsych.2015.11.022. Epub 2015 Dec 5.

9.

Blunted Endogenous Opioid Release Following an Oral Amphetamine Challenge in Pathological Gamblers.

Mick I, Myers J, Ramos AC, Stokes PR, Erritzoe D, Colasanti A, Gunn RN, Rabiner EA, Searle GE, Waldman AD, Parkin MC, Brailsford AD, Galduróz JC, Bowden-Jones H, Clark L, Nutt DJ, Lingford-Hughes AR.

Neuropsychopharmacology. 2016 Jun;41(7):1742-50. doi: 10.1038/npp.2015.340. Epub 2015 Nov 10.

10.

Clinical and neuropsychological correlates of major depression following post-traumatic brain injury, a prospective study.

Mauri MC, Paletta S, Colasanti A, Miserocchi G, Altamura AC.

Asian J Psychiatr. 2014 Dec;12:118-24. doi: 10.1016/j.ajp.2014.07.003. Epub 2014 Aug 18.

PMID:
25193507
11.

What controls DNA looping?

Perez PJ, Clauvelin N, Grosner MA, Colasanti AV, Olson WK.

Int J Mol Sci. 2014 Aug 27;15(9):15090-108. doi: 10.3390/ijms150915090.

12.

Age independently affects myelin integrity as detected by magnetization transfer magnetic resonance imaging in multiple sclerosis.

Newbould RD, Nicholas R, Thomas CL, Quest R, Lee JS, Honeyfield L, Colasanti A, Malik O, Mattoscio M, Matthews PM, Sormani MP, Waldman AD, Muraro PA.

Neuroimage Clin. 2014 Mar 31;4:641-8. doi: 10.1016/j.nicl.2014.02.004. eCollection 2014.

13.

In Vivo Assessment of Brain White Matter Inflammation in Multiple Sclerosis with (18)F-PBR111 PET.

Colasanti A, Guo Q, Muhlert N, Giannetti P, Onega M, Newbould RD, Ciccarelli O, Rison S, Thomas C, Nicholas R, Muraro PA, Malik O, Owen DR, Piccini P, Gunn RN, Rabiner EA, Matthews PM.

J Nucl Med. 2014 Jul;55(7):1112-8. doi: 10.2967/jnumed.113.135129. Epub 2014 Jun 5.

14.

Amphetamine induced endogenous opioid release in the human brain detected with [¹¹C]carfentanil PET: replication in an independent cohort.

Mick I, Myers J, Stokes PR, Erritzoe D, Colasanti A, Bowden-Jones H, Clark L, Gunn RN, Rabiner EA, Searle GE, Waldman AD, Parkin MC, Brailsford AD, Nutt DJ, Lingford-Hughes AR.

Int J Neuropsychopharmacol. 2014 Dec;17(12):2069-74. doi: 10.1017/S1461145714000704. Epub 2014 May 7.

PMID:
24807268
15.

Determination of [(11)C]PBR28 binding potential in vivo: a first human TSPO blocking study.

Owen DR, Guo Q, Kalk NJ, Colasanti A, Kalogiannopoulou D, Dimber R, Lewis YL, Libri V, Barletta J, Ramada-Magalhaes J, Kamalakaran A, Nutt DJ, Passchier J, Matthews PM, Gunn RN, Rabiner EA.

J Cereb Blood Flow Metab. 2014 Jun;34(6):989-94. doi: 10.1038/jcbfm.2014.46. Epub 2014 Mar 19.

16.

In vivo imaging of cerebral dopamine D3 receptors in alcoholism.

Erritzoe D, Tziortzi A, Bargiela D, Colasanti A, Searle GE, Gunn RN, Beaver JD, Waldman A, Nutt DJ, Bani M, Merlo-Pich E, Rabiner EA, Lingford-Hughes A.

Neuropsychopharmacology. 2014 Jun;39(7):1703-12. doi: 10.1038/npp.2014.18. Epub 2014 Jan 28.

17.

Clinical pharmacology of atypical antipsychotics: an update.

Mauri MC, Paletta S, Maffini M, Colasanti A, Dragogna F, Di Pace C, Altamura AC.

EXCLI J. 2014 Oct 13;13:1163-91. eCollection 2014. Review.

18.

Quantification of the specific translocator protein signal of 18F-PBR111 in healthy humans: a genetic polymorphism effect on in vivo binding.

Guo Q, Colasanti A, Owen DR, Onega M, Kamalakaran A, Bennacef I, Matthews PM, Rabiner EA, Turkheimer FE, Gunn RN.

J Nucl Med. 2013 Nov;54(11):1915-23. doi: 10.2967/jnumed.113.121020. Epub 2013 Sep 26.

19.

Bipolar Disorder is associated with the rs6971 polymorphism in the gene encoding 18 kDa Translocator Protein (TSPO).

Colasanti A, Owen DR, Grozeva D, Rabiner EA, Matthews PM, Craddock N, Young AH.

Psychoneuroendocrinology. 2013 Nov;38(11):2826-9. doi: 10.1016/j.psyneuen.2013.07.007. Epub 2013 Aug 12.

20.

Weak operator binding enhances simulated Lac repressor-mediated DNA looping.

Colasanti AV, Grosner MA, Perez PJ, Clauvelin N, Lu XJ, Olson WK.

Biopolymers. 2013 Dec;99(12):1070-81. doi: 10.1002/bip.22336.

21.

Analyzing and building nucleic acid structures with 3DNA.

Colasanti AV, Lu XJ, Olson WK.

J Vis Exp. 2013 Apr 26;(74):e4401. doi: 10.3791/4401.

22.

Insights into Gene Expression and Packaging from Computer Simulations.

Olson WK, Clauvelin N, Colasanti AV, Singh G, Zheng G.

Biophys Rev. 2012 Sep 1;4(3):171-178.

23.

On the psychotropic effects of carbon dioxide.

Colasanti A, Esquivel G, Schruers KJ, Griez EJ.

Curr Pharm Des. 2012;18(35):5627-37. Review.

PMID:
22632467
24.

Internucleosomal interactions mediated by histone tails allow distant communication in chromatin.

Kulaeva OI, Zheng G, Polikanov YS, Colasanti AV, Clauvelin N, Mukhopadhyay S, Sengupta AM, Studitsky VM, Olson WK.

J Biol Chem. 2012 Jun 8;287(24):20248-57. doi: 10.1074/jbc.M111.333104. Epub 2012 Apr 19.

25.

Endogenous opioid release in the human brain reward system induced by acute amphetamine administration.

Colasanti A, Searle GE, Long CJ, Hill SP, Reiley RR, Quelch D, Erritzoe D, Tziortzi AC, Reed LJ, Lingford-Hughes AR, Waldman AD, Schruers KR, Matthews PM, Gunn RN, Nutt DJ, Rabiner EA.

Biol Psychiatry. 2012 Sep 1;72(5):371-7. doi: 10.1016/j.biopsych.2012.01.027. Epub 2012 Mar 3.

PMID:
22386378
26.

Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin.

Carhart-Harris RL, Erritzoe D, Williams T, Stone JM, Reed LJ, Colasanti A, Tyacke RJ, Leech R, Malizia AL, Murphy K, Hobden P, Evans J, Feilding A, Wise RG, Nutt DJ.

Proc Natl Acad Sci U S A. 2012 Feb 7;109(6):2138-43. doi: 10.1073/pnas.1119598109. Epub 2012 Jan 23.

27.

Within-subject comparison of [(11)C]-(+)-PHNO and [(11)C]raclopride sensitivity to acute amphetamine challenge in healthy humans.

Shotbolt P, Tziortzi AC, Searle GE, Colasanti A, van der Aart J, Abanades S, Plisson C, Miller SR, Huiban M, Beaver JD, Gunn RN, Laruelle M, Rabiner EA.

J Cereb Blood Flow Metab. 2012 Jan;32(1):127-36. doi: 10.1038/jcbfm.2011.115. Epub 2011 Aug 31.

28.

Effects of tryptophan depletion and tryptophan loading on the affective response to high-dose CO2 challenge in healthy volunteers.

Colasanti A, Esquivel G, den Boer E, Horlings A, Dandachi A, Oostwegel JL, van Donkelaar EL, Griez EJ, Schruers K.

Psychopharmacology (Berl). 2011 Jun;215(4):739-48. doi: 10.1007/s00213-011-2177-8. Epub 2011 Feb 19.

29.

Symptom dimensions as predictors of clinical outcome, duration of hospitalization, and aggressive behaviours in acutely hospitalized patients with psychotic exacerbation.

Colasanti A, Paletta S, Moliterno D, Mazzocchi A, Mauri MC, Altamura AC.

Clin Pract Epidemiol Ment Health. 2010 Aug 9;6:72-8. doi: 10.2174/1745017901006010072.

30.

Depressive dimension, clinical outcome, and duration of hospitalization in acute schizophrenia.

Mauri MC, Paletta S, Moliterno D, Colasanti A, Altamura CA.

Asian J Psychiatr. 2010 Sep;3(3):121-5. doi: 10.1016/j.ajp.2010.08.004.

PMID:
23051568
31.

Long-range effects of histone point mutations on DNA remodeling revealed from computational analyses of SIN-mutant nucleosome structures.

Xu F, Colasanti AV, Li Y, Olson WK.

Nucleic Acids Res. 2010 Nov;38(20):6872-82. doi: 10.1093/nar/gkq506. Epub 2010 Jul 6.

32.

Genetic moderation of CO2-induced fear by 5-HTTLPR genotype.

Schruers K, Esquivel G, van Duinen M, Wichers M, Kenis G, Colasanti A, Knuts I, Goossens L, Jacobs N, van Rozendaal J, Smeets H, van Os J, Griez E.

J Psychopharmacol. 2011 Jan;25(1):37-42. doi: 10.1177/0269881110372543. Epub 2010 Jun 28.

PMID:
20584994
33.

Opioids and anxiety.

Colasanti A, Rabiner EA, Lingford-Hughes A, Nutt DJ.

J Psychopharmacol. 2011 Nov;25(11):1415-33. doi: 10.1177/0269881110367726. Epub 2010 Jun 8. Review.

PMID:
20530588
34.

3DNALandscapes: a database for exploring the conformational features of DNA.

Zheng G, Colasanti AV, Lu XJ, Olson WK.

Nucleic Acids Res. 2010 Jan;38(Database issue):D267-74. doi: 10.1093/nar/gkp959. Epub 2009 Nov 11.

35.

Benthic foraminifera from the coastal zone of Baia (Naples, Italy): assemblage distribution and modification as tools for environmental characterisation.

Bergamin L, Romano E, Finoia MG, Venti F, Bianchi J, Colasanti A, Ausili A.

Mar Pollut Bull. 2009;59(8-12):234-44. doi: 10.1016/j.marpolbul.2009.09.015. Epub 2009 Oct 14.

PMID:
19833356
36.

Acids in the brain: a factor in panic?

Esquivel G, Schruers KR, Maddock RJ, Colasanti A, Griez EJ.

J Psychopharmacol. 2010 May;24(5):639-47. doi: 10.1177/0269881109104847. Epub 2009 May 21. Review.

PMID:
19460873
37.

Clinical outcome and tolerability of duloxetine in the treatment of major depressive disorder: a 12-week study with plasma levels.

Volonteri LS, Colasanti A, Cerveri G, Fiorentini A, De Gaspari IF, Mauri MC, Valli A, Papa P, Mencacci C.

J Psychopharmacol. 2010 Aug;24(8):1193-9. doi: 10.1177/0269881109104863. Epub 2009 Apr 30.

PMID:
19406851
38.

Neuropsychological functions and metabolic aspects in subclinical hypothyroidism: the effects of L-thyroxine.

Baldini M, Colasanti A, Orsatti A, Airaghi L, Mauri MC, Cappellini MD.

Prog Neuropsychopharmacol Biol Psychiatry. 2009 Aug 1;33(5):854-9. doi: 10.1016/j.pnpbp.2009.04.009. Epub 2009 Apr 21.

PMID:
19389454
39.

Properties of the Nucleic-acid Bases in Free and Watson-Crick Hydrogen-bonded States: Computational Insights into the Sequence-dependent Features of Double-helical DNA.

Srinivasan AR, Sauers RR, Fenley MO, Boschitsch AH, Matsumoto A, Colasanti AV, Olson WK.

Biophys Rev. 2009 Mar 1;1(1):13-20.

40.

Carbon dioxide-induced emotion and respiratory symptoms in healthy volunteers.

Colasanti A, Salamon E, Schruers K, van Diest R, van Duinen M, Griez EJ.

Neuropsychopharmacology. 2008 Dec;33(13):3103-10. doi: 10.1038/npp.2008.31. Epub 2008 Mar 19.

41.

Depression in schizophrenia: comparison of first- and second-generation antipsychotic drugs.

Mauri MC, Moliterno D, Rossattini M, Colasanti A.

Schizophr Res. 2008 Feb;99(1-3):7-12. Epub 2007 Dec 4.

PMID:
18055177
42.

Psychiatric diagnosis and aggression before acute hospitalisation.

Colasanti A, Natoli A, Moliterno D, Rossattini M, De Gaspari IF, Mauri MC.

Eur Psychiatry. 2008 Sep;23(6):441-8. Epub 2007 Nov 19.

PMID:
18024087
43.

Carbon dioxide inhalation induces dose-dependent and age-related negative affectivity.

Griez EJ, Colasanti A, van Diest R, Salamon E, Schruers K.

PLoS One. 2007 Oct 3;2(10):e987.

44.

A novel roll-and-slide mechanism of DNA folding in chromatin: implications for nucleosome positioning.

Tolstorukov MY, Colasanti AV, McCandlish DM, Olson WK, Zhurkin VB.

J Mol Biol. 2007 Aug 17;371(3):725-38. Epub 2007 May 24.

45.

Ziprasidone outcome and tolerability: a practical clinical trial with plasma drug levels.

Mauri MC, Colasanti A, Rossattini M, Volonteri LS, Dragogna F, Fiorentini A, Fiorentini A, Valli A, Papa P.

Pharmacopsychiatry. 2007 May;40(3):89-92.

PMID:
17541882
46.

Clinical pharmacokinetics of atypical antipsychotics: a critical review of the relationship between plasma concentrations and clinical response.

Mauri MC, Volonteri LS, Colasanti A, Fiorentini A, De Gaspari IF, Bareggi SR.

Clin Pharmacokinet. 2007;46(5):359-88. Review.

PMID:
17465637
47.

A single-blind, randomized comparison of olanzapine at a starting dose of 5 mg versus 20 mg in acute schizophrenia.

Mauri MC, Colasanti A, Rossattini M, Moliterno D, Baldi ML, Papa P.

Clin Neuropharmacol. 2006 May-Jun;29(3):126-31.

PMID:
16772810
48.

Substance abuse in first-episode schizophrenic patients: a retrospective study.

Mauri MC, Volonteri LS, De Gaspari IF, Colasanti A, Brambilla MA, Cerruti L.

Clin Pract Epidemiol Ment Health. 2006 Mar 23;2:4.

49.

Parasuicide and drug self-poisoning: analysis of the epidemiological and clinical variables of the patients admitted to the Poisoning Treatment Centre (CAV), Niguarda General Hospital, Milan.

Mauri MC, Cerveri G, Volonteri LS, Fiorentini A, Colasanti A, Manfré S, Borghini R, Pannacciulli E.

Clin Pract Epidemiol Ment Health. 2005 Apr 28;1(1):5.

50.

Combined effects of radiotherapy and photodynamic therapy on an in vitro human prostate model.

Colasanti A, Kisslinger A, Quarto M, Riccio P.

Acta Biochim Pol. 2004;51(4):1039-46.

Supplemental Content

Loading ...
Support Center